Options for the development of a bivalent vaccine against SARS-CoV-2 and influenza

Expert Rev Vaccines. 2022 Nov;21(11):1533-1535. doi: 10.1080/14760584.2022.2117692. Epub 2022 Sep 1.
No abstract available

Keywords: COVID-19; Influenza; SARS-CoV-2; bivalent vaccine; coinfection; viral vectored vaccine.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Influenza Vaccines*
  • Influenza, Human* / prevention & control
  • SARS-CoV-2
  • Vaccines, Combined

Substances

  • COVID-19 Vaccines
  • Vaccines, Combined
  • Influenza Vaccines